{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T21:02:03Z","timestamp":1695502923944},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,12,10]],"date-time":"2008-12-10T00:00:00Z","timestamp":1228867200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1007\/s00702-008-0163-z","type":"journal-article","created":{"date-parts":[[2008,12,9]],"date-time":"2008-12-09T14:46:03Z","timestamp":1228833963000},"page":"89-95","source":"Crossref","is-referenced-by-count":3,"title":["Serotonin-induced decrease of intracellular Ca2+ release in platelets of bulimic patients normalizes during treatment"],"prefix":"10.1007","volume":"116","author":[{"given":"Lars","family":"W\u00f6ckel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian Daniel","family":"Zepf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Koch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anik\u00f3-Eva","family":"Meyer-Keitel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin H.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,12,10]]},"reference":[{"key":"163_CR1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF00504378","volume":"325","author":"H Affolter","year":"1984","unstructured":"Affolter H, Erne P, B\u00fcrgisser E, Pletscher A (1984) Ca2+ as messenger of 5HT2-receptor stimulation in human blood platelets. Nauyn-Schmiedebergs Arch Pharmacol 325:337\u2013342","journal-title":"Nauyn-Schmiedebergs Arch Pharmacol"},{"key":"163_CR2","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/ajmg.b.30387","volume":"141","author":"T Ando","year":"2006","unstructured":"Ando T, Komaki G, Naruo T, Okabe K, Takii M, Kawai K, Konjiki F, Takei M, Oka T, Takeuchi K, Masuda A, Ozaki N, Suematsu H, Denda K, Kurokawa N, Itakura K, Yamaguchi C, Kono M, Suzuki T, Nakai Y, Nishizono-Maher A, Koide M, Murakami K, Nagamine K, Tomita Y, Ookuma K, Tomita K, Tonai E, Ooshima A, Ishikawa T, Ichimaru Y (2006) Possible role of preproghrelin gene polymorphisms in susceptibility to bulimia nervosa. Am J Med Genet B Neuropsychiatr Genet 141:929\u2013934","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"163_CR3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2174\/1568007033338689","volume":"2","author":"UF Bailer","year":"2003","unstructured":"Bailer UF, Kaye WH (2003) A review of neuropeptide and neuroendocrine dysregulation in anorexia and bulimia nervosa. Curr Drug Targets CNS Neurol Disord 2:53\u201359","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"163_CR4","first-page":"356","volume":"22","author":"B Baranowska","year":"2001","unstructured":"Baranowska B, Wolinska-Witort E, Wasilewska-Dziubinska E, Roguski K, Chmielowska M (2001) Plasma leptin, neuropeptide Y (NPY) and galanin concentrations in bulimia nervosa and in anorexia nervosa. Neuro Endocrinol Lett 22:356\u2013358","journal-title":"Neuro Endocrinol Lett"},{"key":"163_CR5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/(SICI)1098-108X(199707)22:1<57::AID-EAT7>3.0.CO;2-1","volume":"22","author":"M Berk","year":"1997","unstructured":"Berk M, Kessa K, Szabo CP, Butkow N (1997) The augmented platelet intracellular calcium response to serotonin in anorexia nervosa but not bulimia may be due to subsyndromal depression. Int J Eat Disord 22:57\u201363","journal-title":"Int J Eat Disord"},{"key":"163_CR6","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/0028-3908(84)90098-4","volume":"23","author":"JE Blundell","year":"1984","unstructured":"Blundell JE (1984) Serotonin and appetite. Neuropharmacology 23:1537\u20131551","journal-title":"Neuropharmacology"},{"key":"163_CR7","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/BF02244862","volume":"114","author":"RA Bothwell","year":"1994","unstructured":"Bothwell RA, Eccleston D, Marshall E (1994) Platelet intracellular calcium in patients with recurrent affective disorders. Psychopharmacol (Berl) 114:375\u2013381","journal-title":"Psychopharmacol (Berl)"},{"key":"163_CR8","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0306-4530(00)00062-7","volume":"26","author":"F Brambilla","year":"2001","unstructured":"Brambilla F, Bellodi L, Arancio C, Ronchi P, Limonta D (2001) Central dopaminergic function in anorexia and bulimia nervosa: a psychoneuroendocrine approach. Psychoneuroendocrinology 26:393\u2013409","journal-title":"Psychoneuroendocrinology"},{"key":"163_CR9","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0306-4530(95)00001-5","volume":"20","author":"TD Brewerton","year":"1995","unstructured":"Brewerton TD (1995) Toward a unified theory of serotonin dysregulation in eating and related disorders. Psychoneuroendocrinology 20:561\u2013590","journal-title":"Psychoneuroendocrinology"},{"key":"163_CR10","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1001\/archpsyc.1992.01820110016002","volume":"49","author":"TD Brewerton","year":"1992","unstructured":"Brewerton TD, Mueller EA, Lesem MD, Brandt HA, Quearry B, George DT, Murphy DL, Jimerson DC (1992) Neuroendocrine responses to m-chlorophenylpiperazine and l-tryptophan in bulimia. Arch Gen Psychiatry 49:852\u2013861","journal-title":"Arch Gen Psychiatry"},{"key":"163_CR11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2174\/187152706777452254","volume":"5","author":"PG Clifton","year":"2006","unstructured":"Clifton PG, Kennett GA (2006) Monoamine receptors in the regulation of feeding behaviour and energy balance. CNS Neurol Disord Drug Targets 5:293\u2013312","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"163_CR12","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1523\/JNEUROSCI.06-12-03669.1986","volume":"6","author":"PJ Conn","year":"1986","unstructured":"Conn PJ, Sanders-Bush E (1986) Regulation of serotonin-stimulated phosphoinositide hydrolysis: relation to the serotonin 5-HT-2 binding site. J Neurosci 6:3669\u20133675","journal-title":"J Neurosci"},{"key":"163_CR13","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1046\/j.1471-4159.1994.63020465.x","volume":"63","author":"EH Cook","year":"1994","unstructured":"Cook EH, Fletcher KE, Wainwright M, Marks N, Yan SY, Leventhal BL (1994) Primary structure of the human platelet serotonin 5-HT2A receptor: identity with frontal cortex serotonin 5-HT2A receptor. J Neurochem 63:465\u2013469","journal-title":"J Neurochem"},{"key":"163_CR14","doi-asserted-by":"crossref","first-page":"7603","DOI":"10.1016\/S0021-9258(17)39651-5","volume":"260","author":"D De Chaffoy de Courcelles","year":"1985","unstructured":"De Chaffoy de Courcelles D, Leysen JE, de Clerck F, van Belle H, Janssen PAJ (1985) Evidence that phospholipid turnover is the signal transducing system coupled to serotonin-S2 receptor sites. J Biol Chem 260:7603\u20137608","journal-title":"J Biol Chem"},{"key":"163_CR15","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0006-3223(97)00377-6","volume":"43","author":"JSM Delisi","year":"1998","unstructured":"Delisi JSM, Konopka LM, O\u2019Connor FL, Crayton JW (1998) Platelet cytosolic calcium responses to serotonin in depressed patients and controls: relationship to symptomatology and medication. Biol Psychiatry 43:327\u2013334","journal-title":"Biol Psychiatry"},{"key":"163_CR16","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/0006-3223(93)90201-N","volume":"34","author":"A Eckert","year":"1993","unstructured":"Eckert A, Gann H, Riemann J, Aldenhoff J, M\u00fcller WE (1993) Elevated intracellular calcium levels after 5-HT2 receptor stimulation in platelets of depressed patients. Biol Psychiatry 34:565\u2013568","journal-title":"Biol Psychiatry"},{"key":"163_CR17","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF02191580","volume":"243","author":"A Eckert","year":"1994","unstructured":"Eckert A, Gann H, Riemann J, Aldenhoff J, M\u00fcller WE (1994) Platelet and lymphocyte free intracellular calcium in affective disorders. Eur Arch Psychiatry Clin Neurosci 243:235\u2013239","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"163_CR18","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1476-5381.1985.tb12939.x","volume":"84","author":"P Erne","year":"1985","unstructured":"Erne P, Pletscher A (1985) Rapid intracellular release of calcium in human platelets by stimulation of 5-HT2-receptors. Br J Pharmacol 84:545\u2013549","journal-title":"Br J Pharmacol"},{"key":"163_CR19","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(03)12378-1","volume":"361","author":"CG Fairburn","year":"2003","unstructured":"Fairburn CG, Harrison PJ (2003) Eating disorders. Lancet 361:407\u2013416","journal-title":"Lancet"},{"key":"163_CR20","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1177\/026988110401800314","volume":"18","author":"S Fassino","year":"2004","unstructured":"Fassino S, Daga GA, Boggio S, Garzaro L, Pier\u00f2 A (2004) Use of reboxetine in bulimia nervosa: a pilot study. J Psychopharmacol 18:423\u2013428","journal-title":"J Psychopharmacol"},{"key":"163_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2007-1014424","volume":"24","author":"MM Fichter","year":"1991","unstructured":"Fichter MM, Leibl L, Rief W, Brunner E, Schmidt-Auberger S, Engel RR (1991) Fluoxetine versus placebo: a double-blind study with bulimic inpatients undergoing intensive psychotherapy. Pharmacopsychiatry 24:1\u20137","journal-title":"Pharmacopsychiatry"},{"key":"163_CR22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/archpsyc.1992.01820020059008","volume":"49","author":"Fluoxetine Bulimia Nervosa Collaborative Study Group","year":"1992","unstructured":"Fluoxetine Bulimia Nervosa Collaborative Study Group (1992) Fluoxetine in the treatment of bulimia nervosa. A multicenter, placebo-controlled, double-blind trial. Arch Gen Psychiatry 49:139\u2013147","journal-title":"Arch Gen Psychiatry"},{"key":"163_CR23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/appe.2001.0407","volume":"37","author":"GK Frank","year":"2001","unstructured":"Frank GK, Kaye WH, Ladenheim EE, McConaha C (2001) Reduced gastrin releasing peptide in cerebrospinal fluid after recovery from bulimia nervosa. Appetite 37:9\u201314","journal-title":"Appetite"},{"key":"163_CR24","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000026481","volume":"37","author":"C Freeman","year":"1998","unstructured":"Freeman C (1998) Drug treatment for bulimia nervosa. Neuropsychobiology 37:72\u201379","journal-title":"Neuropsychobiology"},{"key":"163_CR25","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1192\/bjp.166.5.660","volume":"166","author":"DJ Goldstein","year":"1995","unstructured":"Goldstein DJ, Wilson MG, Thompson VL, Potvin JH, Rampey AH Jr (1995) Long-term fluoxetine treatment of bulimia nervosa. Fluoxetine Bulimia Nervosa Research Group. Br J Psychiatry 166:660\u2013666","journal-title":"Br J Psychiatry"},{"key":"163_CR26","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1476-5381.1979.tb07870.x","volume":"65","author":"M Graf","year":"1979","unstructured":"Graf M, Pletscher A (1979) Shape change of blood platelets\u2014a model for cerebral 5-hydroxytryptamine receptors? Br J Pharmacol 65:601\u2013608","journal-title":"Br J Pharmacol"},{"key":"163_CR27","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1016\/S0021-9258(19)83641-4","volume":"260","author":"G Grynkiewicz","year":"1985","unstructured":"Grynkiewicz G, Poenie M, Tsien RY (1985) A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440\u20133450","journal-title":"J Biol Chem"},{"key":"163_CR28","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1196\/annals.1367.017","volume":"1083","author":"V Hainer","year":"2006","unstructured":"Hainer V, Kabrnova K, Aldhoon B, Kunesova M, Wagenknecht M (2006) Serotonin and norepinephrine reuptake inhibition and eating behavior. Ann N Y Acad Sci 1083:252\u2013269","journal-title":"Ann N Y Acad Sci"},{"key":"163_CR29","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1749-6632.2003.tb03177.x","volume":"994","author":"LK Heisler","year":"2003","unstructured":"Heisler LK, Cowley MA, Kishi T, Tecott LH, Fan W, Low MJ, Smart JL, Rubinstein M, Tatro JB, Zigman JM, Cone RD, Elmquist JK (2003) Central serotonin and melanocortin pathways regulating energy homeostasis. Ann N Y Acad Sci 994:169\u2013174","journal-title":"Ann N Y Acad Sci"},{"key":"163_CR30","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0922-4106(95)90051-9","volume":"288","author":"DM Helmeste","year":"1995","unstructured":"Helmeste DM, Tang SW, Reist C, Vu R (1995) Serotonin uptake inhibitors modulate intracellular Ca2+ mobilization in platelets. Eur J Pharmacol 288:373\u2013377","journal-title":"Eur J Pharmacol"},{"key":"163_CR31","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1749-6632.1990.tb16908.x","volume":"600","author":"DC Jimerson","year":"1990","unstructured":"Jimerson DC, Lesem MD, Hegg AP, Brewerton TD (1990) Serotonin in human eating disorders. Ann N Y Acad Sci 600:532\u2013544","journal-title":"Ann N Y Acad Sci"},{"key":"163_CR32","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1001\/archpsyc.1992.01820020052007","volume":"49","author":"DC Jimerson","year":"1992","unstructured":"Jimerson DC, Lesem MD, Kaye WH, Brewerton TD (1992) Low serotonin and dopamine metabolite concentrations in cerebrospinal fluid from bulimic patients with frequent binge episodes. Arch Gen Psychiatry 49:132\u2013138","journal-title":"Arch Gen Psychiatry"},{"key":"163_CR34","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/archpsyc.1997.01830180043005","volume":"54","author":"DC Jimerson","year":"1997","unstructured":"Jimerson DC, Wolfe BE, Metzger ED, Finkelstein DM, Cooper TB, Levine JM (1997) Decreased serotonin function in bulimia nervosa. Arch Gen Psychiatry 54:529\u2013534","journal-title":"Arch Gen Psychiatry"},{"key":"163_CR33","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1017\/S1092852900009603","volume":"9","author":"DC Jimerson","year":"2004","unstructured":"Jimerson DC, Wolfe BE (2004) Neuropeptides in eating disorders. CNS Spectr 9:516\u2013522","journal-title":"CNS Spectr"},{"issue":"1","key":"163_CR35","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.physbeh.2007.11.037","volume":"94","author":"WH Kaye","year":"2007","unstructured":"Kaye WH (2007) Neurobiology of anorexia and bulimia nervosa. Physiol Behav 94(1):121\u2013135","journal-title":"Physiol Behav"},{"key":"163_CR36","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1176\/ajp.147.2.225","volume":"147","author":"WH Kaye","year":"1990","unstructured":"Kaye WH, Ballenger JC, Lydiard RB, Stuart GW, Laraia MT, O\u2019Neil P, Fossey MD, Stevens V, Lesser S, Hsu G (1990a) CSF monoamine levels in normal-weight bulimia: evidence for abnormal noradrenergic activity. Am J Psychiatry 147:225\u2013229","journal-title":"Am J Psychiatry"},{"key":"163_CR40","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/0006-3223(90)90015-T","volume":"27","author":"WH Kaye","year":"1990","unstructured":"Kaye WH, Gwirtsman HE, George DT, Jimerson DC, Ebert MH, Lake CR (1990b) Disturbances of noradrenergic systems in normal weight bulimia: relationship to diet and menses. Biol Psychiatry 27:4\u201321","journal-title":"Biol Psychiatry"},{"key":"163_CR39","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0006-3223(98)00195-4","volume":"44","author":"WH Kaye","year":"1998","unstructured":"Kaye WH, Gendall K, Strober M (1998) Serotonin neuronal function and selective serotonin reuptake inhibitor treatment in anorexia and bulimia nervosa. Biol Psychiatry 44:825\u2013838","journal-title":"Biol Psychiatry"},{"key":"163_CR38","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0006-3223(99)00108-0","volume":"47","author":"WH Kaye","year":"2000","unstructured":"Kaye WH, Gendall KA, Fernstrom MH, Fernstrom JD, McConaha CW, Weltzin TE (2000) Effects of acute tryptophan depletion on mood in bulimia nervosa. Biol Psychiatry 47:151\u2013157","journal-title":"Biol Psychiatry"},{"key":"163_CR37","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1176\/appi.ajp.158.7.1152","volume":"158","author":"WH Kaye","year":"2001","unstructured":"Kaye WH, Frank GK, Meltzer CC, Price JC, McConaha CW, Crossan PJ, Klump KL, Rhodes L (2001) Altered serotonin 2A receptor activity in women who have recovered from bulimia nervosa. Am J Psychiatry 158:1152\u20131155","journal-title":"Am J Psychiatry"},{"key":"163_CR41","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/0006-3223(95)00189-1","volume":"39","author":"LM Konopka","year":"1996","unstructured":"Konopka LM, Cooper R, Crayton JW (1996) Serotonin-induced increases in platelet cytosolic calcium concentration in depressed, schizophrenic, and substance abuse patients. Biol Psychiatry 39:708\u2013713","journal-title":"Biol Psychiatry"},{"key":"163_CR42","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-244X-7-19","volume":"7","author":"AK Koskela","year":"2007","unstructured":"Koskela AK, Keski-Rahkonen A, Sihvola E, Kauppinen T, Kaprio J, Ahonen A, Rissanen A (2007) Serotonin transporter binding of [123I]ADAM in bulimic women, their healthy twin sisters, and healthy women: a SPET study. BMC Psychiatry 7:19","journal-title":"BMC Psychiatry"},{"key":"163_CR43","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/0006-3223(91)90114-2","volume":"30","author":"I Kusumi","year":"1991","unstructured":"Kusumi I, Koyama T, Yamashita I (1991) Serotonin-stimulated Ca2+ response is increased in the blood platelets of depressed patients. Biol Psychiatry 30:310\u2013312","journal-title":"Biol Psychiatry"},{"key":"163_CR44","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/BF02245204","volume":"113","author":"I Kusumi","year":"1994","unstructured":"Kusumi I, Koyama T, Yamashita I (1994) Serotonin-induced platelet intracellular calcium mobilization in depressed patients. Psychopharmacology 113:322\u2013327","journal-title":"Psychopharmacology"},{"issue":"Suppl 3","key":"163_CR45","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00003495-199000393-00005","volume":"39","author":"SF Leibowitz","year":"1990","unstructured":"Leibowitz SF (1990) The role of serotonin in eating disorders. Drugs 39(Suppl 3):33\u201348","journal-title":"Drugs"},{"key":"163_CR46","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0006-3223(98)00186-3","volume":"44","author":"SF Leibowitz","year":"1998","unstructured":"Leibowitz SF, Alexander JT (1998) Hypothalamic serotonin in control of eating behavior, meal size, and body weight. Biol Psychiatry 44:851\u2013864","journal-title":"Biol Psychiatry"},{"key":"163_CR47","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1111\/j.1471-4159.1993.tb03522.x","volume":"60","author":"KP Lesch","year":"1993","unstructured":"Lesch KP, Wolozin BL, Murphy DL, Reiderer P (1993) Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter. J Neurochem 60:2319\u20132322","journal-title":"J Neurochem"},{"key":"163_CR48","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1001\/archpsyc.1997.01830180027004","volume":"54","author":"RD Levitan","year":"1997","unstructured":"Levitan RD, Kaplan AS, Joffe RT, Levitt AJ, Brown GM (1997) Hormonal and subjective responses to intravenous meta-chlorophenylpiperazine in bulimia nervosa. Arch Gen Psychiatry 54:521\u2013527","journal-title":"Arch Gen Psychiatry"},{"key":"163_CR49","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/0024-3205(88)90362-1","volume":"43","author":"D Marazziti","year":"1988","unstructured":"Marazziti D, Macchi E, Rotondo A, Placidi GF, Cassano GB (1988) Involvement of serotonin system in bulimia. Life Sci 43:2123\u20132126","journal-title":"Life Sci"},{"key":"163_CR51","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0278-5846(91)90040-8","volume":"15","author":"M Mikuni","year":"1991","unstructured":"Mikuni M, Kusumi I, Kagaya A, Kuroda Y, Mori H, Takahashi K (1991) Increased 5-HT-2 receptor function as measured by serotonin-stimulated phosphoinositide hydrolysis in platelets of depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 15:49\u201361","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"163_CR50","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/BF02245410","volume":"106","author":"M Mikuni","year":"1992","unstructured":"Mikuni M, Kagaya A, Takahashi T, Meltzer HY (1992) Serotonin but not norepinephrine-induced calcium mobilization of platelets is enhanced in affective disorders. Psychopharmacology 106:311\u2013314","journal-title":"Psychopharmacology"},{"key":"163_CR52","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/eat.20343","volume":"40","author":"JE Mitchell","year":"2007","unstructured":"Mitchell JE, Agras S, Wonderlich S (2007) Treatment of bulimia nervosa: where are we and where are we going? Int J Eat Disord 40:95\u2013101","journal-title":"Int J Eat Disord"},{"key":"163_CR53","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0024-3205(94)00955-4","volume":"56","author":"Y Okamoto","year":"1995","unstructured":"Okamoto Y, Kagaya A, Shinno H, Motohashi N, Yamawaki S (1995a) Serotonin-induced platelet calcium mobilization is enhanced in mania. Life Sci 56:327\u2013332","journal-title":"Life Sci"},{"key":"163_CR54","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/0006-3223(95)00243-A","volume":"38","author":"Y Okamoto","year":"1995","unstructured":"Okamoto Y, Okamoto Y, Kagaya A, Tamiya S, Fujita Y, Tohoda Y et al (1995b) Serotonin-induced platelet calcium mobilization is enhanced in bulimia nervosa but not in anorexia nervosa. Biol Psychiatry 38:274\u2013276","journal-title":"Biol Psychiatry"},{"key":"163_CR55","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/hup.251","volume":"16","author":"H Plein","year":"2001","unstructured":"Plein H, Berk M (2001) The platelet as a peripheral marker in psychiatric illness. Hum Psychopharmacol Clin Exp 16:229\u2013236","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"163_CR56","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0165-1781(03)00059-3","volume":"118","author":"CE Ramacciotti","year":"2003","unstructured":"Ramacciotti CE, Coli E, Paoli R, Marazziti D, Dell\u2019Osso L (2003) Serotonergic activity measured by platelet [3H]paroxetine binding in patients with eating disorders. Psychiatry Res 118:33\u201338","journal-title":"Psychiatry Res"},{"key":"163_CR57","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/scientificamerican1089-66","volume":"261","author":"H Rasmussen","year":"1989","unstructured":"Rasmussen H (1989) The cycling of calcium as an intracellular messenger. Sci Am 261:44\u201351","journal-title":"Sci Am"},{"key":"163_CR79","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1749-6632.1986.tb46563.x","volume":"488","author":"TJ Resink","year":"1986","unstructured":"Resink TJ, Dimitrov D, Zschauer A, Erne P, Tkachuk VA, B\u00fchler FR (1986) Platelet calcium-linked abnormalities in essential hypertension. Ann N Y Acad Sci 488:252\u2013265","journal-title":"Ann N Y Acad Sci"},{"key":"163_CR58","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jpsychires.2006.09.001","volume":"42","author":"M Ribas\u00e9s","year":"2008","unstructured":"Ribas\u00e9s M, Fern\u00e1ndez-Aranda F, Gratac\u00f2s M, Mercader JM, Casasnovas C, N\u00fa\u00f1ez A, Vallejo J, Estivill X (2008) Contribution of the serotonergic system to anxious and depressive traits that may be partially responsible for the phenotypical variability of bulimia nervosa. J Psychiatry Res 42:50\u201357","journal-title":"J Psychiatry Res"},{"key":"163_CR59","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/0028-3908(84)90244-2","volume":"23","author":"BL Roth","year":"1984","unstructured":"Roth BL, Nakaki T, Chuang DM, Costa E (1984) Aortic recognition sites for serotonin (5-HT) are coupled to phospholipase C and modulate phosphatidylinositol turnover. Neuropharmacol 23:1223\u20131225","journal-title":"Neuropharmacol"},{"key":"163_CR60","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/eat.20018","volume":"36","author":"DM Sloan","year":"2004","unstructured":"Sloan DM, Mizes JS, Helbok C, Muck R (2004) Efficacy of sertraline for bulimia nervosa. Int J Eat Disord 36:48\u201354","journal-title":"Int J Eat Disord"},{"key":"163_CR61","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1001\/archpsyc.56.2.171","volume":"56","author":"KA Smith","year":"1999","unstructured":"Smith KA, Fairburn CG, Cowen PJ (1999) Symptomatic relapse in bulimia nervosa following acute tryptophan depletion. Arch Gen Psychiatry 56:171\u2013176","journal-title":"Arch Gen Psychiatry"},{"key":"163_CR62","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0924-977X(99)00012-7","volume":"9","author":"O Spigset","year":"1999","unstructured":"Spigset O, Andersen T, H\u00e4gg S, Mj\u00f6rndal T (1999) Enhanced platelet serotonin 5-HT2A receptor binding in anorexia and bulimia nervosa. Eur Neuropsychopharmacol 9:469\u2013473","journal-title":"Eur Neuropsychopharmacol"},{"key":"163_CR63","first-page":"20","volume":"29","author":"H Steiger","year":"2004","unstructured":"Steiger H (2004) Eating disorders and the serotonin connection: state, trait and developmental effects. Rev Psychiatr Neurosci 29:20\u201329","journal-title":"Rev Psychiatr Neurosci"},{"key":"163_CR65","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1017\/S003329179900313X","volume":"31","author":"H Steiger","year":"2001","unstructured":"Steiger H, Young SN, Ng Ying Kin NM, Koerner N, Israel M, Lageix P, Paris J (2001) Implications of impulsive and affective symptoms for serotonin function in bulimia nervosa. Psychol Med 31:85\u201395","journal-title":"Psychol Med"},{"key":"163_CR64","doi-asserted-by":"crossref","first-page":"830","DOI":"10.4088\/JCP.v65n0615","volume":"64","author":"H Steiger","year":"2004","unstructured":"Steiger H, Gauvin L, Israel M, Ng Ying Kin NMK, Young SN, Roussin L (2004) Serotonin function, personality-trait variations, and childhood abuse in women with bulimia-spectrum eating disorders. J Clin Psychiatry 64:830\u2013837","journal-title":"J Clin Psychiatry"},{"key":"163_CR66","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0006-3223(96)00499-4","volume":"41","author":"N Sudo","year":"1997","unstructured":"Sudo N, Sogawa H, Komaki G, Kubo C (1997) The serotonin-induced elevation of intracellular Ca2+ in human platelets is enhanced by total fasting. Biol Psychiatry 41:618\u2013620","journal-title":"Biol Psychiatry"},{"key":"163_CR67","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/sj.npp.1300159","volume":"28","author":"K Suzuki","year":"2003","unstructured":"Suzuki K, Kusumi I, Akimoto T, Sasaki Y, Koyama T (2003) Altered 5-HT-induced calcium response in the presence of staurosporine in blood platelets from bipolar disorders. Neuropsychopharmacology 28:1210\u20131214","journal-title":"Neuropsychopharmacology"},{"key":"163_CR68","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0165-0327(00)00221-4","volume":"64","author":"K Suzuki","year":"2001","unstructured":"Suzuki K, Kusumi I, Sasaki Y, Koyama T (2001) Serotonin-induced platelet intracellular calcium mobilization in various psychiatric disorders: is it specific to bipolar disorder? J Affect Disord 64:291\u2013296","journal-title":"J Affect Disord"},{"key":"163_CR69","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0006-3223(00)00951-3","volume":"49","author":"J Tauscher","year":"2001","unstructured":"Tauscher J, Pirker W, Willeit M, de Zwaan M, Bailer U, Neumeister A, Asenbaum S, Lennkh C, Praschak-Rieder N, Brucke T, Kasper S (2001) [123]beta-CIT and single photon emission computed tomography reveal reduced brain serotonin transporter availability in bulimia nervosa. Biol Psychiatry 49:326\u2013332","journal-title":"Biol Psychiatry"},{"key":"163_CR70","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.cmet.2007.09.012","volume":"6","author":"LH Tecott","year":"2007","unstructured":"Tecott LH (2007) Serotonin and the orchestration of energy balance. Cell Metab 6:352\u2013361","journal-title":"Cell Metab"},{"key":"163_CR71","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.biopsych.2003.12.016","volume":"55","author":"J Tiihonen","year":"2004","unstructured":"Tiihonen J, Keski-Rahkonen A, L\u00f6pp\u00f6nen M, Muhonen M, Kajander J, Allonen T, N\u00e5gren K, Hietala J, Rissanen A (2004) Brain serotonin 1A receptor binding in bulimia nervosa. Biol Psychiatry 55:871\u2013873","journal-title":"Biol Psychiatry"},{"key":"163_CR72","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/S0006-3223(98)00171-1","volume":"45","author":"R Tomiyoshi","year":"1999","unstructured":"Tomiyoshi R, Kamei K, Muraoka S, Muneoka K, Takigawa M (1999) Serotonin-induced platelet intracellular Ca2+ responses in untreated depressed patients and imipramine responders in remission. Biol Psychiatry 45:1042\u20131048","journal-title":"Biol Psychiatry"},{"key":"163_CR74","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/0306-4603(95)00091-7","volume":"20","author":"BT Walsh","year":"1995","unstructured":"Walsh BT, Devlin MJ (1995) Pharmacotherapy of bulimia nervosa and binge eating disorder. Addict Behav 20:757\u2013764","journal-title":"Addict Behav"},{"key":"163_CR73","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1176\/appi.ajp.157.8.1332","volume":"157","author":"BT Walsh","year":"2000","unstructured":"Walsh BT, Agras WS, Devlin MJ, Fairburn CG, Wilson GT, Kahn C, Chally MK (2000) Fluoxetine for bulimia nervosa following poor response to psychotherapy. Am J Psychiatry 157:1332\u20131334","journal-title":"Am J Psychiatry"},{"key":"163_CR75","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1176\/appi.ajp.161.3.556","volume":"161","author":"BT Walsh","year":"2004","unstructured":"Walsh BT, Fairburn CG, Mickley D, Sysko R, Parides MK (2004) Treatment of bulimia nervosa in a primary care setting. Am J Psychiatry 161:556\u2013561","journal-title":"Am J Psychiatry"},{"key":"163_CR77","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/0006-3223(94)90005-1","volume":"35","author":"TE Weltzin","year":"1994","unstructured":"Weltzin TE, Fernstrom JD, McConaha C, Kaye WH (1994) Acute tryptophan depletion in bulimia: effects on large neutral amino acids. Biol Psychiatry 35:388\u2013397","journal-title":"Biol Psychiatry"},{"key":"163_CR76","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1176\/ajp.152.11.1668","volume":"152","author":"TE Weltzin","year":"1995","unstructured":"Weltzin TE, Fernstrom MH, Fernstrom JD, Neuberger SK, Kaye WH (1995) Acute tryptophan depletion and increased food intake and irritability in bulimia nervosa. Am J Psychiatry 152:1668\u20131671","journal-title":"Am J Psychiatry"},{"key":"163_CR78","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1055\/s-2007-992145","volume":"41","author":"L W\u00f6ckel","year":"2008","unstructured":"W\u00f6ckel L, Koch S, Stadler C, Meyer-Keitel A-E, Schmidt MH (2008) Serotonin-induced platelet intracellular Ca2+ response in patients with anorexia nervosa. Pharmacopsychiatry 41:10\u201316","journal-title":"Pharmacopsychiatry"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-008-0163-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-008-0163-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-008-0163-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T07:48:38Z","timestamp":1632728918000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-008-0163-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,10]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["163"],"URL":"https:\/\/doi.org\/10.1007\/s00702-008-0163-z","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,10]]}}}